Contemporary Management of Hemophilia A: Expert Guidance to Improve Patient Outcomes

Building from a solid foundation based on direct factor VIII replacement, management of hemophilia A now includes nonfactor therapies. Here’s my take on progress and future directions.

Guy A. Young, MD Released: October 14, 2020

Get an expert’s thoughts on key data most likely to affect care of patients with hemophilia presented at ASH 2020.

Stacy E. Croteau, MD, MMS Released: December 18, 2020

Read a discussion with 3 experts answering audience questions following 2 live Webcasts on contemporary management of hemophilia A.

Michael Callaghan, MD Miguel A. Escobar, MD Rebecca Kruse-Jarres, MD, MPH Released: February 16, 2021

Download this slideset to learn more about up-to-date management strategies to optimize outcomes for patients with hemophilia A.

Michael Callaghan, MD Released: December 3, 2020

Learn more about strategies to mitigate complications associated with factor replacement therapy and overcoming barriers to effective therapy

Rebecca Kruse-Jarres, MD, MPH Released: December 4, 2020

Learn about the latest data on nonfactor replacement therapies and their evolving role in the management of hemophilia A in by downloading this slideset.

Miguel A. Escobar, MD Released: December 4, 2020

Download this summary slideset of key takeaways from a CCO Live Webinar for expert insight on contemporary best practice management of hemophilia A, including prophylaxis, improving adherence, and emerging strategies to improve patient outcomes.

Michael Callaghan, MD Miguel A. Escobar, MD Rebecca Kruse-Jarres, MD, MPH Released: December 10, 2020

Learn about contemporary management of hemophilia A from a panel of experts in this on-demand Webcast from a live Webinar.

Miguel A. Escobar, MD
Program Director Michael Callaghan, MD Rebecca Kruse-Jarres, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: December 10, 2020 Expired: December 9, 2021

With updates from ASH 2020, current management of hemophilia A is discussed by a panel of experts in this on-demand Webcast from a live Webinar.

Miguel A. Escobar, MD
Program Director Michael Callaghan, MD Rebecca Kruse-Jarres, MD, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: February 25, 2021 Expired: February 24, 2022

In this podcast episode, listen to Michael Callaghan, MD; Miguel A. Escobar, MD; and Rebecca Kruse-Jarres, MD, MPH, as they answer questions from a clinician audience on new and established approaches for managing hemophilia A in pediatric and adult patients.

Michael Callaghan, MD Miguel A. Escobar, MD Rebecca Kruse-Jarres, MD, MPH Released: February 4, 2021